In 2016, our studies involved 25 countries and 302.340 patients, covering these areas



EU H2020 grant for unique HIT-CYSTIC FIBROSIS project

The EU has granted €6.7 M from the Horizon 2020 research program to a broad collaborative group of researchers, doctors, pharmaceutical companies and patient representatives. Julius Clinical is one of the consortium partners and will be responsible for global Site Management, Monitoring, Data Ma

read more

Our Partners


Julius Clinical runs high quality innovative trials with the input of scientific experts to impact the future of medicine.

read more